Nexentis Technologies Inc.
NXTSNasdaqCIK 1789192HealthcareFiscal year ends Dec 31
Reports and events: 147 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1920:05 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors | 0001493152-26-047578 |
| 2026-10-0613:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-045885 |
| 2026-09-0320:05 ET | 8-K | 3.01 Delisting notice | 0001493152-26-041358 |
| 2026-08-1320:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037757 |
| 2026-08-0620:06 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-036335 |
| 2026-07-1320:05 ET | S-1 | Registration statement | 0001493152-26-033026 |
| 2026-06-2220:49 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-029611 |
| 2026-06-1220:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-028439 |
| 2026-05-2720:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-025397 |
| 2026-05-1420:21 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023107 |
| 2026-04-3020:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-020509 |
| 2026-04-0612:39 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-015246 |
| 2026-03-3120:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-014183 |
| 2026-03-1720:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-010533 |
| 2026-03-1215:26 ET | DEF 14A | Proxy statementPeriod 2026-03-12 | 0001493152-26-009810 |
| 2026-02-2621:17 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-26-008175 |
| 2026-02-2514:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure | 0001493152-26-007988 |
| 2026-01-1321:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-002031 |
| 2026-01-1214:15 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-26-001247 |
| 2025-12-1621:05 ET | 8-K | 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001493152-25-027962 |
| 2025-11-1321:32 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022355 |
| 2025-11-1221:06 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-021907 |
| 2025-11-0321:05 ET | DEF 14A | Proxy statementPeriod 2025-11-03 | 0001493152-25-020585 |
| 2025-10-2320:01 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019064 |
| 2025-10-0813:05 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017377 |
| 2025-09-2520:30 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-014952 |
| 2025-09-1813:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013998 |
| 2025-09-0920:15 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-012904 |
| 2025-08-1920:42 ET | S-1/A | Registration statement, amended | 0001493152-25-012164 |
| 2025-08-1820:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-012130 |
| 2025-08-1420:21 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011990 |
| 2025-08-1422:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-011919 |
| 2025-08-0620:06 ET | S-1 | Registration statement | 0001641172-25-022425 |
| 2025-08-0520:01 ET | DEF 14A | Proxy statementPeriod 2025-08-05 | 0001641172-25-022235 |
| 2025-07-2810:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-011426 |
| 2025-07-2420:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-011380 |
| 2025-05-2220:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-012067 |
| 2025-05-1520:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010883 |
| 2025-05-1321:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-009993 |
| 2025-05-1220:10 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors | 0001641172-25-009678 |
| 2025-04-1020:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-003600 |
| 2025-03-3113:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001513 |
| 2025-03-3110:15 ET | 8-K | 3.01 Delisting notice | 0001641172-25-001431 |
| 2025-03-2013:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-010993 |
| 2025-03-1713:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-010502 |
| 2025-02-2814:15 ET | 8-K | 1.01 Entry into a material agreement | 0001493152-25-008629 |
| 2025-02-2614:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008294 |
| 2025-02-1414:43 ET | S-1/A | Registration statement, amended | 0001493152-25-006622 |
| 2025-02-0721:24 ET | S-1/A | Registration statement, amended | 0001493152-25-005400 |
| 2025-02-0715:31 ET | 8-K | 8.01 Other events | 0001493152-25-005327 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.